HomeHealthcare & Life Sciences Human Biospecimens Market

Global Human Biospecimens Market Size, Share & Trends Analysis Report By Specimen Type (Tissue SpecimensFFPE (Formalin-Fixed Paraffin-Embedded) TissueFresh Frozen TissueTumor BiopsiesNormal Tissue Samples, BiofluidsWhole BloodPlasmaSerumUrineSalivaCSF (Cerebrospinal Fluid)Fastest Growing: Plasma, Cellular MaterialPBMCs (Peripheral Blood Mononuclear Cells)Buccal CellsStem Cells, Nucleic AcidsGenomic DNARNActDNA/cfDNA (circulating tumor/DNA) â Fastest Growing), By Ap (Cancer Research, Drug Disco

Starting From
USD 3950

Buy Now

Report Benefits

Develop business strategies by understanding the trends shaping and driving the Market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track sales in the global and country-specific Market.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Executive Summary
1. Introduction
Market Introduction
1. Market Definition
2. Scope of the Study
3. Market Structure
Research Methodology
1. Primary Research
2. Research Methodology
3. Assumptions & Exclusions
4. Secondary Data Sources
Market Factor Analysis
1. Value Chain Analysis: Human Biospecimens Market
2. Porters Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of Substitution
  4. Threat of New Entrants
  5. Competitive Rivalry
Market Dynamics
1. Drivers
2. Restraints
3. Opportunities
Recent Trends Analysis
Impact of COVID-19 on Human Biospecimens Market
1. Pre and Post Covid -19 Market Scenario Analysis
2. Market Recovery Timeline and Challenge
3. Measures Taken by Top Players
Regulatory Landscape
Human Biospecimens Market, By Specimen Type
1. Introduction
  1. Market Size and Forecast, By Specimen Type
2. Tissue Specimens
  1. Market Size and Forecast, By Region
  2. FFPE (Formalin-Fixed Paraffin-Embedded) Tissue
    1. Market Size and Forecast, By Region
  3. Fresh Frozen Tissue
    1. Market Size and Forecast, By Region
  4. Tumor Biopsies
    1. Market Size and Forecast, By Region
  5. Normal Tissue Samples
    1. Market Size and Forecast, By Region
3. Biofluids
  1. Market Size and Forecast, By Region
  2. Whole Blood
    1. Market Size and Forecast, By Region
  3. Plasma
    1. Market Size and Forecast, By Region
  4. Serum
    1. Market Size and Forecast, By Region
  5. Urine
    1. Market Size and Forecast, By Region
  6. Saliva
    1. Market Size and Forecast, By Region
  7. CSF (Cerebrospinal Fluid)
    1. Market Size and Forecast, By Region
  8. Fastest Growing: Plasma
    1. Market Size and Forecast, By Region
4. Cellular Material
  1. Market Size and Forecast, By Region
  2. PBMCs (Peripheral Blood Mononuclear Cells)
    1. Market Size and Forecast, By Region
  3. Buccal Cells
    1. Market Size and Forecast, By Region
  4. Stem Cells
    1. Market Size and Forecast, By Region
5. Nucleic Acids
  1. Market Size and Forecast, By Region
  2. Genomic DNA
    1. Market Size and Forecast, By Region
  3. RNA
    1. Market Size and Forecast, By Region
  4. ctDNA/cfDNA (circulating tumor/DNA) – Fastest Growing
    1. Market Size and Forecast, By Region
Human Biospecimens Market, By Ap
1. Introduction
  1. Market Size and Forecast, By Ap
2. Cancer Research
  1. Market Size and Forecast, By Region
3. Drug Discovery and Development
  1. Market Size and Forecast, By Region
4. Diagnostics and Biomarker Discovery
  1. Market Size and Forecast, By Region
5. Translational and Genomic Research
  1. Market Size and Forecast, By Region
6. Precision Medicine
  1. Market Size and Forecast, By Region
7. Infectious Disease Studies (e.g., COVID-19, HIV, TB)
  1. Market Size and Forecast, By Region
8. Neurology and Cardiovascular Research
  1. Market Size and Forecast, By Region
Human Biospecimens Market, By End Use
1. Introduction
  1. Market Size and Forecast, By End Use
2. Pharmaceutical and Biotechnology Companies
  1. Market Size and Forecast, By Region
3. Contract Research Organizations (CROs)
  1. Market Size and Forecast, By Region
4. Academic and Research Institutes
  1. Market Size and Forecast, By Region
5. Hospitals and Biobanks
  1. Market Size and Forecast, By Region
6. Diagnostic Laboratories
  1. Market Size and Forecast, By Region
7. Government and Non-Profit Organizations
  1. Market Size and Forecast, By Region
Human Biospecimens Market, By Storage Type
1. Introduction
  1. Market Size and Forecast, By Storage Type
2. Cold Storage (−80°C or LN2)
  1. Market Size and Forecast, By Region
3. Ambient/Room Temperature Stabilized
  1. Market Size and Forecast, By Region
4. Cryogenic (Liquid Nitrogen, −196°C)
  1. Market Size and Forecast, By Region
5. Formalin-Fixed Storage
  1. Market Size and Forecast, By Region
Human Biospecimens Market, By Procurement Type
1. Introduction
  1. Market Size and Forecast, By Procurement Type
2. Prospective Collection (On-Demand Collection)
  1. Market Size and Forecast, By Region
3. Retrospective/Banked Samples
  1. Market Size and Forecast, By Region
Regional Overview
1. Introduction
  1. Market Size and Forecast
2. North America
  1. Market Size and Forecast
    1. By Specimen Type
      1. Tissue Specimens
      2. Biofluids
      3. Cellular Material
      4. Nucleic Acids
    2. By Ap
      1. Cancer Research
      2. Drug Discovery and Development
      3. Diagnostics and Biomarker Discovery
      4. Translational and Genomic Research
      5. Precision Medicine
      6. Infectious Disease Studies (e.g., COVID-19, HIV, TB)
      7. Neurology and Cardiovascular Research
    3. By End Use
      1. Pharmaceutical and Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic and Research Institutes
      4. Hospitals and Biobanks
      5. Diagnostic Laboratories
      6. Government and Non-Profit Organizations
    4. By Storage Type
      1. Cold Storage (−80°C or LN2)
      2. Ambient/Room Temperature Stabilized
      3. Cryogenic (Liquid Nitrogen, −196°C)
      4. Formalin-Fixed Storage
    5. By Procurement Type
      1. Prospective Collection (On-Demand Collection)
      2. Retrospective/Banked Samples
  2. U.S.
    1. By Specimen Type
      1. Tissue Specimens
      2. Biofluids
      3. Cellular Material
      4. Nucleic Acids
    2. By Ap
      1. Cancer Research
      2. Drug Discovery and Development
      3. Diagnostics and Biomarker Discovery
      4. Translational and Genomic Research
      5. Precision Medicine
      6. Infectious Disease Studies (e.g., COVID-19, HIV, TB)
      7. Neurology and Cardiovascular Research
    3. By End Use
      1. Pharmaceutical and Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic and Research Institutes
      4. Hospitals and Biobanks
      5. Diagnostic Laboratories
      6. Government and Non-Profit Organizations
    4. By Storage Type
      1. Cold Storage (−80°C or LN2)
      2. Ambient/Room Temperature Stabilized
      3. Cryogenic (Liquid Nitrogen, −196°C)
      4. Formalin-Fixed Storage
    5. By Procurement Type
      1. Prospective Collection (On-Demand Collection)
      2. Retrospective/Banked Samples
  3. Canada
3. Europe
  1. Market Size and Forecast
    1. By Specimen Type
      1. Tissue Specimens
      2. Biofluids
      3. Cellular Material
      4. Nucleic Acids
    2. By Ap
      1. Cancer Research
      2. Drug Discovery and Development
      3. Diagnostics and Biomarker Discovery
      4. Translational and Genomic Research
      5. Precision Medicine
      6. Infectious Disease Studies (e.g., COVID-19, HIV, TB)
      7. Neurology and Cardiovascular Research
    3. By End Use
      1. Pharmaceutical and Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic and Research Institutes
      4. Hospitals and Biobanks
      5. Diagnostic Laboratories
      6. Government and Non-Profit Organizations
    4. By Storage Type
      1. Cold Storage (−80°C or LN2)
      2. Ambient/Room Temperature Stabilized
      3. Cryogenic (Liquid Nitrogen, −196°C)
      4. Formalin-Fixed Storage
    5. By Procurement Type
      1. Prospective Collection (On-Demand Collection)
      2. Retrospective/Banked Samples
  2. U.K.
    1. By Specimen Type
      1. Tissue Specimens
      2. Biofluids
      3. Cellular Material
      4. Nucleic Acids
    2. By Ap
      1. Cancer Research
      2. Drug Discovery and Development
      3. Diagnostics and Biomarker Discovery
      4. Translational and Genomic Research
      5. Precision Medicine
      6. Infectious Disease Studies (e.g., COVID-19, HIV, TB)
      7. Neurology and Cardiovascular Research
    3. By End Use
      1. Pharmaceutical and Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic and Research Institutes
      4. Hospitals and Biobanks
      5. Diagnostic Laboratories
      6. Government and Non-Profit Organizations
    4. By Storage Type
      1. Cold Storage (−80°C or LN2)
      2. Ambient/Room Temperature Stabilized
      3. Cryogenic (Liquid Nitrogen, −196°C)
      4. Formalin-Fixed Storage
    5. By Procurement Type
      1. Prospective Collection (On-Demand Collection)
      2. Retrospective/Banked Samples
  3. Germany
  4. France
  5. Spain
  6. Italy
  7. Russia
  8. Nordic
  9. Benelux
  10. Rest of Europe
4. APAC
  1. Market Size and Forecast
    1. By Specimen Type
      1. Tissue Specimens
      2. Biofluids
      3. Cellular Material
      4. Nucleic Acids
    2. By Ap
      1. Cancer Research
      2. Drug Discovery and Development
      3. Diagnostics and Biomarker Discovery
      4. Translational and Genomic Research
      5. Precision Medicine
      6. Infectious Disease Studies (e.g., COVID-19, HIV, TB)
      7. Neurology and Cardiovascular Research
    3. By End Use
      1. Pharmaceutical and Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic and Research Institutes
      4. Hospitals and Biobanks
      5. Diagnostic Laboratories
      6. Government and Non-Profit Organizations
    4. By Storage Type
      1. Cold Storage (−80°C or LN2)
      2. Ambient/Room Temperature Stabilized
      3. Cryogenic (Liquid Nitrogen, −196°C)
      4. Formalin-Fixed Storage
    5. By Procurement Type
      1. Prospective Collection (On-Demand Collection)
      2. Retrospective/Banked Samples
  2. China
    1. By Specimen Type
      1. Tissue Specimens
      2. Biofluids
      3. Cellular Material
      4. Nucleic Acids
    2. By Ap
      1. Cancer Research
      2. Drug Discovery and Development
      3. Diagnostics and Biomarker Discovery
      4. Translational and Genomic Research
      5. Precision Medicine
      6. Infectious Disease Studies (e.g., COVID-19, HIV, TB)
      7. Neurology and Cardiovascular Research
    3. By End Use
      1. Pharmaceutical and Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic and Research Institutes
      4. Hospitals and Biobanks
      5. Diagnostic Laboratories
      6. Government and Non-Profit Organizations
    4. By Storage Type
      1. Cold Storage (−80°C or LN2)
      2. Ambient/Room Temperature Stabilized
      3. Cryogenic (Liquid Nitrogen, −196°C)
      4. Formalin-Fixed Storage
    5. By Procurement Type
      1. Prospective Collection (On-Demand Collection)
      2. Retrospective/Banked Samples
  3. South Korea
  4. Japan
  5. India
  6. Australia
  7. Singapore
  8. Taiwan
  9. South East Asia
  10. Rest of Asia-Pacific
5. Middle East and Africa
  1. Market Size and Forecast
    1. By Specimen Type
      1. Tissue Specimens
      2. Biofluids
      3. Cellular Material
      4. Nucleic Acids
    2. By Ap
      1. Cancer Research
      2. Drug Discovery and Development
      3. Diagnostics and Biomarker Discovery
      4. Translational and Genomic Research
      5. Precision Medicine
      6. Infectious Disease Studies (e.g., COVID-19, HIV, TB)
      7. Neurology and Cardiovascular Research
    3. By End Use
      1. Pharmaceutical and Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic and Research Institutes
      4. Hospitals and Biobanks
      5. Diagnostic Laboratories
      6. Government and Non-Profit Organizations
    4. By Storage Type
      1. Cold Storage (−80°C or LN2)
      2. Ambient/Room Temperature Stabilized
      3. Cryogenic (Liquid Nitrogen, −196°C)
      4. Formalin-Fixed Storage
    5. By Procurement Type
      1. Prospective Collection (On-Demand Collection)
      2. Retrospective/Banked Samples
  2. UAE
    1. By Specimen Type
      1. Tissue Specimens
      2. Biofluids
      3. Cellular Material
      4. Nucleic Acids
    2. By Ap
      1. Cancer Research
      2. Drug Discovery and Development
      3. Diagnostics and Biomarker Discovery
      4. Translational and Genomic Research
      5. Precision Medicine
      6. Infectious Disease Studies (e.g., COVID-19, HIV, TB)
      7. Neurology and Cardiovascular Research
    3. By End Use
      1. Pharmaceutical and Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic and Research Institutes
      4. Hospitals and Biobanks
      5. Diagnostic Laboratories
      6. Government and Non-Profit Organizations
    4. By Storage Type
      1. Cold Storage (−80°C or LN2)
      2. Ambient/Room Temperature Stabilized
      3. Cryogenic (Liquid Nitrogen, −196°C)
      4. Formalin-Fixed Storage
    5. By Procurement Type
      1. Prospective Collection (On-Demand Collection)
      2. Retrospective/Banked Samples
  3. Turky
  4. Saudi Arabia
  5. South Africa
  6. Egypt
  7. Nigeria
  8. Rest of MEA
6. LATAM
  1. Market Size and Forecast
    1. By Specimen Type
      1. Tissue Specimens
      2. Biofluids
      3. Cellular Material
      4. Nucleic Acids
    2. By Ap
      1. Cancer Research
      2. Drug Discovery and Development
      3. Diagnostics and Biomarker Discovery
      4. Translational and Genomic Research
      5. Precision Medicine
      6. Infectious Disease Studies (e.g., COVID-19, HIV, TB)
      7. Neurology and Cardiovascular Research
    3. By End Use
      1. Pharmaceutical and Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic and Research Institutes
      4. Hospitals and Biobanks
      5. Diagnostic Laboratories
      6. Government and Non-Profit Organizations
    4. By Storage Type
      1. Cold Storage (−80°C or LN2)
      2. Ambient/Room Temperature Stabilized
      3. Cryogenic (Liquid Nitrogen, −196°C)
      4. Formalin-Fixed Storage
    5. By Procurement Type
      1. Prospective Collection (On-Demand Collection)
      2. Retrospective/Banked Samples
  2. Brazil
    1. By Specimen Type
      1. Tissue Specimens
      2. Biofluids
      3. Cellular Material
      4. Nucleic Acids
    2. By Ap
      1. Cancer Research
      2. Drug Discovery and Development
      3. Diagnostics and Biomarker Discovery
      4. Translational and Genomic Research
      5. Precision Medicine
      6. Infectious Disease Studies (e.g., COVID-19, HIV, TB)
      7. Neurology and Cardiovascular Research
    3. By End Use
      1. Pharmaceutical and Biotechnology Companies
      2. Contract Research Organizations (CROs)
      3. Academic and Research Institutes
      4. Hospitals and Biobanks
      5. Diagnostic Laboratories
      6. Government and Non-Profit Organizations
    4. By Storage Type
      1. Cold Storage (−80°C or LN2)
      2. Ambient/Room Temperature Stabilized
      3. Cryogenic (Liquid Nitrogen, −196°C)
      4. Formalin-Fixed Storage
    5. By Procurement Type
      1. Prospective Collection (On-Demand Collection)
      2. Retrospective/Banked Samples
  3. Mexico
  4. Argentina
  5. Chile
  6. Colombia
  7. Rest of LATAM
Competitive Landscape, 2025
1. Introduction
2. Human Biospecimens Market Share Analysis, 2025 (%)
  1. Market Share Analysis, 2025
  2. Competition Ranking, 2025
  3. Key Developments & Growth Strategies
    1. Merger & Acquisition
    2. Product Launch
    3. Expansion
  4. Consolidated SWOT Analysis of Key Players
Company Profile
1. Discovery Life Sciences
  1. Business Overview
  2. Financial Data
  3. Key Product Categories
  4. Recent Developments
2. Precision for Medicine
3. BioIVT
4. iSpecimen
5. Azenta Life Sciences
6. Charles River Laboratories
7. Thermo Fisher Scientific
8. QIAGEN
9. ProteoGenex
10. Cureline
11. Boca Biolistics
12. StemExpress
13. AMSBIO
14. Tissue Solutions
15. Cerba Research

Report Benefits

Table of Contents